2023 Q1 Form 10-Q Financial Statement
#000149315223003998 Filed on February 09, 2023
Income Statement
Concept | 2023 Q1 | 2022 Q4 | 2021 Q4 |
---|---|---|---|
Revenue | $1.617M | $1.546M | |
YoY Change | 646700.0% | ||
Cost Of Revenue | $880.0K | $681.0K | $0.00 |
YoY Change | |||
Gross Profit | $737.0K | $865.0K | $0.00 |
YoY Change | 294700.0% | ||
Gross Profit Margin | 45.58% | 55.95% | |
Selling, General & Admin | $1.427M | $1.337M | $522.4K |
YoY Change | 116.41% | 155.93% | |
% of Gross Profit | 193.62% | 154.57% | |
Research & Development | $168.0K | $135.0K | $129.6K |
YoY Change | 19.22% | 4.13% | |
% of Gross Profit | 22.8% | 15.61% | |
Depreciation & Amortization | $45.00K | $45.00K | $45.00K |
YoY Change | 0.0% | 0.0% | |
% of Gross Profit | 6.11% | 5.2% | |
Operating Expenses | $1.595M | $1.472M | $652.1K |
YoY Change | 99.3% | 125.75% | |
Operating Profit | -$858.0K | -$607.0K | -$652.1K |
YoY Change | 7.24% | -6.91% | |
Interest Expense | $0.00 | ||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | $2.000K | $5.000K | |
YoY Change | |||
Pretax Income | -$856.0K | -$602.0K | -$652.1K |
YoY Change | 6.99% | -7.68% | |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$856.0K | -$602.0K | -$652.1K |
YoY Change | 6.99% | -7.68% | |
Net Earnings / Revenue | -52.94% | -38.94% | |
Basic Earnings Per Share | -$0.01 | $0.00 | $0.01 |
Diluted Earnings Per Share | -$0.01 | $0.00 | -$7.841K |
COMMON SHARES | |||
Basic Shares Outstanding | 148.9M shares | 148.7M shares | 59.90M shares |
Diluted Shares Outstanding | 148.9M shares | 148.7M shares |
Balance Sheet
Concept | 2023 Q1 | 2022 Q4 | 2021 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $1.902M | $2.553M | $5.072M |
YoY Change | -56.67% | -49.66% | |
Cash & Equivalents | $1.902M | $2.553M | $5.072M |
Short-Term Investments | |||
Other Short-Term Assets | $463.0K | $454.0K | $388.8K |
YoY Change | 43.25% | 16.76% | |
Inventory | |||
Prepaid Expenses | $283.0K | $274.0K | |
Receivables | $896.0K | $570.0K | |
Other Receivables | $0.00 | $0.00 | |
Total Short-Term Assets | $3.261M | $3.577M | $5.460M |
YoY Change | -30.81% | -34.49% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $0.00 | ||
YoY Change | |||
Goodwill | $1.356M | $1.356M | |
YoY Change | |||
Intangibles | $4.940M | $4.940M | |
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $240.0K | $285.0K | |
YoY Change | -42.86% | ||
Total Long-Term Assets | $6.536M | $6.581M | $465.0K |
YoY Change | 1456.19% | 1315.27% | |
TOTAL ASSETS | |||
Total Short-Term Assets | $3.261M | $3.577M | $5.460M |
Total Long-Term Assets | $6.536M | $6.581M | $465.0K |
Total Assets | $9.797M | $10.16M | $5.925M |
YoY Change | 90.85% | 71.43% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $765.0K | $698.0K | $1.289M |
YoY Change | 76.39% | -45.84% | |
Accrued Expenses | $0.00 | ||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $50.00K | $50.00K | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $1.382M | $1.017M | $1.289M |
YoY Change | 218.65% | -21.09% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $1.382M | $1.017M | $1.289M |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $1.593M | $1.228M | $1.289M |
YoY Change | 267.3% | -4.72% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$13.39M | -$12.54M | |
YoY Change | |||
Common Stock | $150.0K | $149.0K | |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $8.204M | $8.930M | $4.637M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $9.797M | $10.16M | $5.925M |
YoY Change | 90.85% | 71.43% |
Cashflow Statement
Concept | 2023 Q1 | 2022 Q4 | 2021 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$856.0K | -$602.0K | -$652.1K |
YoY Change | 6.99% | -7.68% | |
Depreciation, Depletion And Amortization | $45.00K | $45.00K | $45.00K |
YoY Change | 0.0% | 0.0% | |
Cash From Operating Activities | -$651.0K | -$477.0K | -$712.4K |
YoY Change | -4.48% | -33.04% | |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | $0.00 | |
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | $0.00 | ||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $0.00 | ||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | ||
YoY Change | |||
NET CHANGE | |||
Cash From Operating Activities | -651.0K | -$477.0K | -712.4K |
Cash From Investing Activities | 0.000 | ||
Cash From Financing Activities | 0.000 | ||
Net Change In Cash | -651.0K | -$477.0K | $0.00 |
YoY Change | -4.48% | ||
FREE CASH FLOW | |||
Cash From Operating Activities | -$651.0K | -$477.0K | -$712.4K |
Capital Expenditures | $0.00 | $0.00 | |
Free Cash Flow | -$651.0K | -$477.0K | -$712.4K |
YoY Change | -4.48% | -33.04% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q4 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001022505 | |
CY2022Q4 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022Q4 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2022Q4 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--09-30 | |
CY2022Q4 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
usd | |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2021Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
usd | |
CY2021Q4 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
usd | |
CY2021Q4 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
usd | |
CY2022Q4 | SDCH |
Increase Decrease In Unbilled Revenue
IncreaseDecreaseInUnbilledRevenue
|
usd | |
CY2021Q4 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
usd | |
CY2022Q4 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
usd | |
CY2021Q4 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
usd | |
CY2022Q4 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2021Q4 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2022Q4 | SDCH |
Equity Redemptions Related To Financing Activies
EquityRedemptionsRelatedToFinancingActivies
|
usd | |
CY2022Q4 | SDCH |
Equity Distributions Related To Financing Activies
EquityDistributionsRelatedToFinancingActivies
|
usd | |
CY2022Q4 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
usd | |
CY2022Q4 | SDCH |
Business Acquisitions Pro Forma Income Tax
BusinessAcquisitionsProFormaIncomeTax
|
usd | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
|
shares | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
||
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
|
shares | |
CY2022Q4 | SDCH |
Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Outstanding Weighted Average Exercise Price Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsOutstandingWeightedAverageExercisePriceExercised
|
||
CY2022Q4 | dei |
Document Type
DocumentType
|
10-Q | |
CY2022Q4 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2022Q4 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-12-31 | |
CY2022Q4 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022Q4 | dei |
Entity File Number
EntityFileNumber
|
000-28745 | |
CY2022Q4 | dei |
Entity Registrant Name
EntityRegistrantName
|
SideChannel, Inc. | |
CY2022Q4 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2022Q4 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
86-0837077 | |
CY2022Q4 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
146 Main Street | |
CY2022Q4 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 405 | |
CY2022Q4 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Worcester | |
CY2022Q4 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
MA | |
CY2022Q4 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
01608 | |
CY2022Q4 | dei |
City Area Code
CityAreaCode
|
(508) | |
CY2022Q4 | dei |
Local Phone Number
LocalPhoneNumber
|
925-0114 | |
CY2022Q4 | dei |
Security12b Title
Security12bTitle
|
Common Stock, par value $0.001 per share | |
CY2022Q4 | dei |
Trading Symbol
TradingSymbol
|
SDCH | |
CY2022Q4 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022Q4 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022Q4 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022Q4 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022Q4 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2022Q4 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
148904613 | shares |
CY2021Q4 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-511000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-477000 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2553000 | usd |
CY2022Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3030000 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
570000 | usd |
CY2022Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
612000 | usd |
CY2022Q4 | us-gaap |
Deferred Costs Current
DeferredCostsCurrent
|
180000 | usd |
CY2022Q3 | us-gaap |
Deferred Costs Current
DeferredCostsCurrent
|
180000 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
274000 | usd |
CY2022Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
320000 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
3577000 | usd |
CY2022Q3 | us-gaap |
Assets Current
AssetsCurrent
|
4142000 | usd |
CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
1356000 | usd |
CY2022Q3 | us-gaap |
Goodwill
Goodwill
|
1356000 | usd |
CY2022Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
4940000 | usd |
CY2022Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
4940000 | usd |
CY2022Q4 | us-gaap |
Deferred Costs
DeferredCosts
|
285000 | usd |
CY2022Q3 | us-gaap |
Deferred Costs
DeferredCosts
|
330000 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
10158000 | usd |
CY2022Q3 | us-gaap |
Assets
Assets
|
10768000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
698000 | usd |
CY2022Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
786000 | usd |
CY2022Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
74000 | usd |
CY2022Q3 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
130000 | usd |
CY2022Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
50000 | usd |
CY2022Q3 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
50000 | usd |
CY2022Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
195000 | usd |
CY2022Q3 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
195000 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1017000 | usd |
CY2022Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1161000 | usd |
CY2022Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
211000 | usd |
CY2022Q3 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
211000 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
1228000 | usd |
CY2022Q3 | us-gaap |
Liabilities
Liabilities
|
1372000 | usd |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2022Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
100 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
100 | shares |
CY2022Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
100 | shares |
CY2022Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
100 | shares |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
681000000 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
681000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
148904613 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
148904613 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
148724056 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
148724056 | shares |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
149000 | usd |
CY2022Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
149000 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
21316000 | usd |
CY2022Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
21180000 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-12535000 | usd |
CY2022Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-11933000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8930000 | usd |
CY2022Q4 | us-gaap |
Gross Profit
GrossProfit
|
865000 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9396000 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
10158000 | usd |
CY2022Q4 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
681000 | usd |
CY2021Q4 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
476000 | usd |
CY2022Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
10768000 | usd |
CY2022Q4 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1546000 | usd |
CY2021Q4 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1048000 | usd |
CY2021Q4 | us-gaap |
Gross Profit
GrossProfit
|
572000 | usd |
CY2022Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1030000 | usd |
CY2021Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
205000 | usd |
CY2022Q4 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
307000 | usd |
CY2021Q4 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
43000 | usd |
CY2022Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
135000 | usd |
CY2022Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
1472000 | usd |
CY2021Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
248000 | usd |
CY2022Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-607000 | usd |
CY2021Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
324000 | usd |
CY2022Q4 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
5000 | usd |
CY2021Q4 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
4000 | usd |
CY2022Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-602000 | usd |
CY2021Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
328000 | usd |
CY2022Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
CY2021Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.01 | |
CY2022Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
148733860 | shares |
CY2021Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
59900000 | shares |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
427000 | usd |
CY2021Q4 | SDCH |
Equity Redemptions
EquityRedemptions
|
-100000 | usd |
CY2021Q4 | SDCH |
Equity Distributions
EquityDistributions
|
-461000 | usd |
CY2021Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
328000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
194000 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9396000 | usd |
CY2022Q4 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
18000 | usd |
CY2022Q4 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
118000 | usd |
CY2022Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-602000 | usd |
CY2022Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-602000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8930000 | usd |
CY2022Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-602000 | usd |
CY2021Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
328000 | usd |
CY2022Q4 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
45000 | usd |
CY2022Q4 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
115000 | usd |
CY2022Q4 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-42000 | usd |
CY2021Q4 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-136000 | usd |
CY2021Q4 | SDCH |
Increase Decrease In Unbilled Revenue
IncreaseDecreaseInUnbilledRevenue
|
-95000 | usd |
CY2022Q4 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-46000 | usd |
CY2022Q4 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-67000 | usd |
CY2021Q4 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
163000 | usd |
CY2022Q4 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-56000 | usd |
CY2021Q4 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-130000 | usd |
CY2022Q4 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-477000 | usd |
CY2021Q4 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
592000 | usd |
CY2021Q4 | SDCH |
Equity Redemptions Related To Financing Activies
EquityRedemptionsRelatedToFinancingActivies
|
50000 | usd |
CY2021Q4 | SDCH |
Equity Distributions Related To Financing Activies
EquityDistributionsRelatedToFinancingActivies
|
461000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
81000 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
3030000 | usd |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
348000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
2553000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
429000 | usd |
CY2022Q4 | SDCH |
Stockbased Compensation Included In Accounts Payable And Accrued Liabilities
StockbasedCompensationIncludedInAccountsPayableAndAccruedLiabilities
|
21000 | usd |
CY2021Q4 | SDCH |
Equity Redemption With Note Payable
EquityRedemptionWithNotePayable
|
50000 | usd |
CY2022Q3 | us-gaap |
Share Price
SharePrice
|
0.10 | |
CY2022Q3 | SDCH |
Fair Value Of Closing Shares
FairValueOfClosingShares
|
6100000 | usd |
CY2022Q4 | SDCH |
Fair Value Of Closing Shares
FairValueOfClosingShares
|
5300000 | usd |
CY2022Q4 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
1048 | usd |
CY2022Q4 | SDCH |
Business Acquisitions Pro Forma Cost Of Revenue
BusinessAcquisitionsProFormaCostOfRevenue
|
-476 | usd |
CY2022Q4 | SDCH |
Business Acquisitions Pro Forma Gross Profit
BusinessAcquisitionsProFormaGrossProfit
|
572 | usd |
CY2022Q4 | SDCH |
Business Acquisitions Pro Forma Operating Expenses
BusinessAcquisitionsProFormaOperatingExpenses
|
900 | usd |
CY2022Q4 | SDCH |
Business Acquisitions Pro Forma Operating Loss
BusinessAcquisitionsProFormaOperatingLoss
|
-328 | usd |
CY2022Q4 | SDCH |
Business Acquisitions Pro Forma Other Income
BusinessAcquisitionsProFormaOtherIncome
|
4 | usd |
CY2022Q4 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
-324 | usd |
CY2022Q4 | us-gaap |
Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
|
-324 | usd |
CY2022Q4 | us-gaap |
Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
|
-0.00 | |
CY2022Q4 | us-gaap |
Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
|
148100000 | shares |
CY2022Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
74000 | usd |
CY2022Q3 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
130000 | usd |
CY2022Q4 | SDCH |
Contract With Customer Liability Deferral Of Revenue
ContractWithCustomerLiabilityDeferralOfRevenue
|
13000 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
69000 | usd |
CY2022Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
74000 | usd |
CY2022Q4 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1546000 | usd |
CY2021Q4 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1048000 | usd |
CY2022Q4 | SDCH |
Increase Decrease In Revenue From Contract With Customer
IncreaseDecreaseInRevenueFromContractWithCustomer
|
498000 | usd |
CY2022Q4 | SDCH |
Increase Decrease In Revenue From Contract With Customer Percentage
IncreaseDecreaseInRevenueFromContractWithCustomerPercentage
|
0.475 | pure |
CY2022Q4 | us-gaap |
Payments For Fees
PaymentsForFees
|
36000 | usd |
CY2022Q4 | us-gaap |
Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
|
0 | usd |
CY2022Q4 | SDCH |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms One
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsOne
|
P5Y7D | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
|
75000 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
2.00 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
|
87718920 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
115000 | usd |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000 | shares |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2021Q4 | us-gaap |
Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
|
489000 | usd |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
148904613 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
59900000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
681000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
681000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
100 | shares |
CY2022Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
|
87793920 | shares |
CY2022Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
0.56 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
0.56 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
|
P4Y8M4D |